Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients w...
Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma
About this item
Full title
Author / Creator
Chen, Cunte , Liu, Sichu , Jiang, Xinmiao , Huang, Ling , Chen, Feili , Wei, Xiaojun , Guo, Hanguo , Shao, Yang , Li, Yangqiu and Li, Wenyu
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Tumor mutation burden (TMB) as estimated by cancer gene panels (CGPs) has been confirmed to be associated with prognosis and is effective in predicting clinical benefit from immune checkpoint blockade (ICB) in solid tumors. However, whether the TMB calculated by CGPs is associated with overall survival (OS) for patients with diffuse large B-cell ly...
Alternative Titles
Full title
Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_534ed6599fe44536ad68e5219fc195b9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_534ed6599fe44536ad68e5219fc195b9
Other Identifiers
ISSN
2162-3619
E-ISSN
2162-3619
DOI
10.1186/s40164-021-00215-4
